Literature DB >> 16113512

Characteristics of patients with chronic cough who developed classic asthma during the course of cough variant asthma: a longitudinal study.

Takeo Nakajima1, Yoshihiro Nishimura, Teruaki Nishiuma, Yoshikazu Kotani, Yasuhiro Funada, Hiroyuki Nakata, Mitsuhiro Yokoyama.   

Abstract

BACKGROUND: Some patients develop asthmatic symptoms such as wheezing and dyspnea during the course of cough variant asthma (CVA), which are considered precursors of classical asthma.
OBJECTIVES: To identify the characteristics of such patients, we investigated the nature of CVA patients with or without developing bronchial asthma in the longitudinal study.
METHODS: In 28 CVA patients whom we could observe over 5 years, duration of coughing, physical examination findings, pulmonary function and bronchial hyperresponsiveness to inhaled methacholine were retrospectively assessed.
RESULTS: Of these patients with CVA, 10 developed the asthmatic symptoms of wheezing and dyspnea (precursors of classical asthma) over 5 years. All these 10 patients showed marked bronchial hyperresponsiveness; however, there were no significant differences in the bronchial responsiveness to methacholine between patients with precursors of classical asthma and pure CVA patients who did not wheeze. The duration of coughing had a significant relationship with precursors of classical asthma. Seven patients with precursors of classical asthma developed wheezing in the first year and 1 patient each in the second, third and fourth year.
CONCLUSIONS: These findings of a 5-year observation suggest that longer duration of coughing may be an important factor that develops precursors of classical asthma in patients with CVA. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16113512     DOI: 10.1159/000087459

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

1.  Clinical study on treatment of cough variant asthma by Chinese medicine.

Authors:  Qing Miao; Peng-Cao Wei; Mao-Rong Fan; Yan-Ping Zhang
Journal:  Chin J Integr Med       Date:  2013-07-02       Impact factor: 1.978

2.  Retrospective Study of the Effects of Post-nasal Drip Symptoms on Cough Duration.

Authors:  Takeo Nakajima; Tatsuya Nagano; Yoshihiro Nishimura
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

3.  An Open-Label, Multi-Institutional, Randomized Study to Evaluate the Additive Effect of a Leukotriene Receptor Antagonist on Cough Score in Patients with Cough-Variant Asthma Being Treated with Inhaled Corticosteroids.

Authors:  Nanako Miwa; Tatsuya Nagano; Hisashi Ohnishi; Teruaki Nishiuma; Kazuhiro Takenaka; Tomohiko Shirotani; Takeo Nakajima; Ryota Dokuni; Yoshitaka Kawa; Kazuyuki Kobayashi; Yasuhiro Funada; Yoshikazu Kotani; Yoshihiro Nishimura
Journal:  Kobe J Med Sci       Date:  2018-12-04

4.  Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant Asthma.

Authors:  Takeo Nakajima; Tatsuya Nagano; Yoshihiro Nishimura
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

5.  Usefulness Analysis of Fraction of Exhaled Nitric Oxide for the Differential Diagnosis of Acute Cough.

Authors:  Takeo Nakajima; Tatsuya Nagano; Teruaki Nishiuma; Kyosuke Nakata; Yoshihiro Nishimura
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

6.  Mechanism of Action of Yin Nourishing and Heat Clearing Prescription in Treating Cough Variant Asthma Based on Network Pharmacology and Molecular Docking Verification.

Authors:  Yin Zhang; Yixin Cui; Qi Chen; Fagen Li; Shaodan Li
Journal:  Comput Math Methods Med       Date:  2022-07-12       Impact factor: 2.809

7.  Therapeutic Effects of Kangzhi Syrup in a Guinea Pig Model of Ovalbumin-Induced Cough Variant Asthma.

Authors:  Youpeng Wang; Pengyu Zhu; Jiejun Tan; Zhiwei Liu; Wanying Qu; Lujia Liu; Zhijun Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-23       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.